Discover how machine learning is helping researchers identify different groups of chronic obstructive pulmonary disease (COPD ...

From CHEST 2021, Dr MeiLan Han reports on real-world evidence studies affecting patients with COPD, including results from the PRIMUS study.

Patients with COPD who exhibit low blood eosinophil counts had no change in exacerbations or survival compared with patients with typical counts.

Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations.

Budesonide-formoterol inhaler was as effective as fluticasone-salmeterol in reducing the incidence of moderate-severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) ...

During the ATS 2021 session “Clinical Advances in Pulmonary Hypertension: Lessons from Best Abstracts,” investigators reported that patients in the open-label extension period of the trial on ...

A national audit shows Irish hospitals are saving more lives from heart disease and stroke, though data quality gaps remain ...

Due to misleading claims in a sales aid for Breztri Aerosphere, a triple inhaled therapy for COPD, the FDA has issued a warning letter to its manufacturer, AstraZeneca. Breztri Aerosphere is a ...